I am a scientist with a wide breadth of experience across several areas including, but not limited to: biochemistry, stem cell biology, developmental biology, molecular biology, and computational biology. I have worked with many different organisms throughout my scientific training, including: plants and microalgae, frogs, fish, as well as adherent and suspension cell lines, and murine and human intestinal organoids. I have also acquired a wide range of technical skills, some of which are more developed than others. My strengths lie in being strategic, adaptable, persistent, and creative. I now work at Vertex Pharmaceuticals as a research scientist where I strive to be an innovative problem-solver to deliver on our commitment to patients with chronic and life-threatening disease. I am currently working on research projects critical to developing a functional cure for Duchenne Muscular Dystrophy at Vertex Cell and Gene Therapies (VCGT) on Yi-Li Min's team. I previously worked on the Sickle Cell Disease small molecule program as a Vertex Fellow ('23-'24) on Caline Matar's team (Human Disease Modeling and Mechanisms at Boston Research). Prior to my time at Vertex, I was a graduate student in Allon Klein's lab at Harvard Medical School, where I received a PhD in Systems Biology in May 2023 for my work on the intrinsic capacity of the small intestine epithelium to regenerate during homeostasis and injury. As an undergraduate, I studied Biochemistry and worked in the lab of Pam Weathers, where I completed my undergraduate thesis on transcriptional changes and their relationship to the production of the anti-malarial drug artemisinin via grafting experiments of the plant that naturally produces the drug (Artemisia annua).I've always been driven by a mix of relentless curiosity, a passion for problem-solving, and a determination to have a meaningfully positive impact on the world. It's an honor to be working on research projects that have the potential to save peoples' lives.